Larvol Delta - A2-Biotherapeutics-Announces-FDA-Clearance-of-IND-for-A2B543-for-Treatment-of-Adults-with-Recurrent-Unresectable-Locally-Advanced-or-Metastatic-Solid-Tumors-that-Express-Mesothelin-and-Have-Lost-HLAA02-Expression

A2B543 - A2 Biotherap

https://www.a2bio.com/a2-biotherapeutics-announces-fda-clearance-of-ind-for-a2b543-for-treatment-of-adults-with-recurrent-unresectable-locally-advanced-or-metastatic-solid-tumors-that-express-mesothelin-and-have-lost-hla/

Jan 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next